BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18360848)

  • 1. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
    Park SJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):184. PubMed ID: 17630660
    [No Abstract]   [Full Text] [Related]  

  • 7. Are we totally clear?
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):987-8. PubMed ID: 19953511
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
    Byrne RA; Kastrati A
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term results of the "Endeavor" stent.
    Kornovski R
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):996-9. PubMed ID: 19953512
    [No Abstract]   [Full Text] [Related]  

  • 10. What kind of stent for you today and how would you like it prepared?
    Butman SM
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):173-4. PubMed ID: 17630654
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical presentation of patients with late target lesion revascularization.
    Kaneda H
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):749. PubMed ID: 18942148
    [No Abstract]   [Full Text] [Related]  

  • 12. "Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization?
    Bailey SR
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):457-8. PubMed ID: 18819143
    [No Abstract]   [Full Text] [Related]  

  • 13. Stent fracture-unusual cause of DES restenosis.
    Goyal BK
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):993-4. PubMed ID: 17525958
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 16. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term safety: not only a drug eluting stents issue.
    Fineschi M; ZacĂ  V; Gori T
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1051; author reply 1052. PubMed ID: 18044789
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.